Dr. Gilberto Ramirez , MD
Internal Medicine • Bloomfield, CT
421 Cottage Grove Rd, Suite A
Bloomfield, CT 060023119
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Gilberto Ramirez is listed in NPPES under Internal Medicine.
-
NPI assigned on July 26, 2006; this date does not establish years in practice.
-
Published CMS data list 1,396 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 484 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 426 service units.
- 87811 — Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19): 84 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 18,972 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 1,225 prescription fills, including refills.
- Trazodone Hcl — 737 prescription fills, including refills.
- Amlodipine Besylate — 712 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 227 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 19 clinicians with data). Median for this group: 580. Middle half: 331 to 1,082.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine in Connecticut (2024, 1,500 clinicians with data). Median for this group: 498. Middle half: 204 to 901.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,088 in 2020 to 1,396 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
421 Cottage Grove Rd
Suite A
Bloomfield, CT 060023119
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Ponce School Of Medicine
1984
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
329 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $82,967 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $59,229 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
28,945 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,051,712 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,707.15 across 81 records.
By nature of payment
- Food and Beverage: $1,707.15 across 81 records.
Reporting-company totals (3 largest of 19)
- AstraZeneca Pharmaceuticals LP: $334.62 across 15 records.
- ABBVIE INC.: $157.40 across 10 records.
- Amgen Inc.: $156.72 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
42 years (graduated 1984)
CMS Doctors and Clinicians data list 1984 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ramirez has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ramirez as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bloomfield and Connecticut
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 19 clinicians with data). Median for this group: 580. Middle half: 331 to 1,082.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine in Connecticut (2024, 1,500 clinicians with data). Median for this group: 498. Middle half: 204 to 901.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 19 clinicians with data). Median for this group: $43,145. Middle half: $31,121 to $80,475.
A higher Medicare-allowed amount than 70% of clinicians listed under Internal Medicine in Connecticut (2024, 1,500 clinicians with data). Median for this group: $50,793. Middle half: $22,001 to $86,184.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 19 clinicians with data). Median for this group: $32,606. Middle half: $23,925 to $59,824.
A higher Medicare payment amount than 65% of clinicians listed under Internal Medicine in Connecticut (2024, 1,500 clinicians with data). Median for this group: $39,329. Middle half: $16,463 to $67,151.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 21 clinicians with data). Median for this group: 4,971. Middle half: 3,028 to 8,521.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Connecticut (2024, 1,571 clinicians with data). Median for this group: 1,218. Middle half: 98 to 4,433.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Bloomfield, CT (2024, 21 clinicians with data). Median for this group: $410,178. Middle half: $348,558 to $766,983.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Connecticut (2024, 1,571 clinicians with data). Median for this group: $91,415. Middle half: $3,967 to $384,333.
28 active clinicians are listed under Internal Medicine with a practice address in Bloomfield, CT (2,625 in Connecticut).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bloomfield
39.3% of these 28 clinicians have the CMS telehealth indicator.
64.3% of these 28 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 28% from 1,088 in 2020 to 1,396 in 2024.
- 2020: 1,088
- 2021: 1,671
- 2022: 1,453
- 2023: 1,156
- 2024: 1,396
-
Medicare-allowed amount
Medicare-allowed amount decreased 15% from $97,085 in 2020 to $82,967 in 2024.
- 2020: $97,085
- 2021: $145,897
- 2022: $106,648
- 2023: $88,567
- 2024: $82,967
-
Paid by Medicare
Paid by Medicare decreased 21% from $74,568 in 2020 to $59,229 in 2024.
- 2020: $74,568
- 2021: $122,943
- 2022: $87,335
- 2023: $66,451
- 2024: $59,229
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 19,497 in 2020 and 18,972 in 2024.
- 2020: 19,497
- 2021: 18,572
- 2022: 20,795
- 2023: 20,839
- 2024: 18,972
-
30-day fills
30-day fills stayed about the same: 28,799 in 2020 and 28,945 in 2024.
- 2020: 28,799
- 2021: 27,935
- 2022: 29,801
- 2023: 30,111
- 2024: 28,945
-
Part D drug cost
Part D drug cost increased 22% from $1,675,685 in 2020 to $2,051,712 in 2024.
- 2020: $1,675,685
- 2021: $1,839,494
- 2022: $2,175,479
- 2023: $2,370,559
- 2024: $2,051,712
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 19% from $2,108.80 in 2021 to $1,707.15 in 2025.
- 2021: $2,108.80
- 2022: $1,657.83
- 2023: $1,800.65
- 2024: $1,411.82
- 2025: $1,707.15
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 81 records totaling $1,707.15.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $31.00 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $29.30 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $28.75 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $28.15 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $27.92 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $27.75 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $27.44 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BEVESPI AEROSPHERE | General | $26.87 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $26.17 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $25.79 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $25.70 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $25.32 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $25.26 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $25.21 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $25.18 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $25.18 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $25.13 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $25.05 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $24.87 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $24.76 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PAXLOVID | General | $24.72 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $24.69 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $24.42 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $24.36 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
484 | 220 | $146.37 | $89.44 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
426 | 229 | $20.01 | $16.00 |
|
87811
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
|
84 | 74 | $80.14 | $40.23 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
80 | 80 | $218.13 | $110.87 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
80 | 43 | $211.50 | $125.81 |
|
87804
Detection test by immunoassay with direct visual observation for influenza virus
|
62 | 30 | $32.16 | $16.22 |
|
81002
Urinalysis, manual test
|
45 | 34 | $16.00 | $3.41 |
|
87880
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)
|
32 | 28 | $43.22 | $15.69 |
|
99305
Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes
|
30 | 16 | $250.00 | $129.89 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
25 | 25 | $275.00 | $128.40 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
21 | 21 | $80.00 | $14.26 |
|
G0008
Administration of influenza virus vaccine
|
15 | 13 | $55.00 | $33.90 |
|
90662
Influenza vaccine split virus, preservative free
|
12 | 11 | $90.00 | $81.00 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1,225 | 65,738 | $16,064.94 | 237 |
| Trazodone Hcl | Trazodone Hcl | 737 | 28,396 | $12,711.47 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 712 | 38,935 | $6,875.71 | 136 |
| Lisinopril | Lisinopril | 583 | 34,170 | $5,243.79 | 123 |
| Omeprazole | Omeprazole | 495 | 31,121 | $9,219.27 | 132 |
| Furosemide | Furosemide | 430 | 17,838 | $2,991.72 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 394 | 19,251 | $6,713.41 | 75 |
| Gabapentin | Gabapentin | 359 | 12,164 | $8,155.43 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 342 | 20,612 | $3,261.47 | 67 |
| Mirtazapine | Mirtazapine | 342 | 10,704 | $8,837.31 | 51 |
| Eliquis | Apixaban | 336 | 7,310 | $146,486.85 | 36 |
| Metformin Hcl | Metformin Hcl | 332 | 18,770 | $3,571.07 | 79 |
| Escitalopram Oxalate | Escitalopram Oxalate | 319 | 11,719 | $9,518.46 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 314 | 13,554 | $4,470.89 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 312 | 16,042 | $4,956.68 | 63 |
| Jardiance | Empagliflozin | 302 | 11,097 | $225,502.85 | 41 |
| Carvedilol | Carvedilol | 283 | 11,674 | $4,451.39 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 260 | 17,866 | $834.07 | 61 |
| Prednisone | Prednisone | 256 | 5,256 | $1,387.86 | 126 |
| Sertraline Hcl | Sertraline Hcl | 234 | 8,616 | $4,303.24 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 226 | 7,864 | $4,999.36 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 211 | 16,996 | $1,892.52 | 64 |
| Farxiga | Dapagliflozin Propanediol | 206 | 8,041 | $154,432.17 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 199 | 9,731 | $2,459.65 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 180 | 8,114 | $4,319.21 | 27 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207Q00000X
Family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20040521001077
CT
8729079249
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Osteopathic Medicine (D.O.)
Family Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 421 COTTAGE GROVE RD, SUITE A, BLOOMFIELD, CT 060023119 (Tel: 8602423933)
Registered at 421 COTTAGE GROVE RD, SUITE A, BLOOMFIELD, CT 060023119 (Tel: 8602423933)
Recorded as GILBERTO RAMIREZ, MD
Family Medicine (license number reported to NPPES: CT 028497)
NPI status registered as active in NPPES database
Registered at 421 COTTAGE GROVE RD, SUITE A, BLOOMFIELD, CT 060023119 (Tel: 8602423933)
Registered at 421 COTTAGE GROVE RD, SUITE A, BLOOMFIELD, CT 060023119 (Tel: 8602423933)
Recorded as GILBERTO RAMIREZ, MD
Family Medicine (license number reported to NPPES: CT 028497)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Bloomfield
- Dr. Herbert Keating, MD
- Dr. Bechara Barrak, MD
- Dr. Irina Muni, MD
- Dr. John Wenceslao, MD
- Dr. Alona Kantorovich, MD
- Dr. Munish Shastri, MD
Mailing Address
421 Cottage Grove Rd, Suite A
Bloomfield, CT 060023119
Phone: 8602423933